Cancer immunotherapy using tumor-infiltrating lymphocytes

Semin Hematol. 1992 Apr;29(2 Suppl 1):33-5.

Author

R A Figlin¹

Affiliation

¹ Bowyer Oncology Center, University of California, Los Angeles.

PMID: 1535456

No abstract available

Publication types

Clinical Trial

MeSH terms

CD8 Antigens / analysis
Carcinoma, Renal Cell / surgery
Carcinoma, Renal Cell / therapy*
Cell Separation / methods
Combined Modality Therapy
Humans
Immunologic Factors / therapeutic use
Immunotherapy, Adoptive*
Interferon-alpha / therapeutic use
Interleukin-2 / therapeutic use
Kidney Neoplasms / surgery
Kidney Neoplasms / therapy*
Lymphocytes, Tumor-Infiltrating / immunology
Lymphocytes, Tumor-Infiltrating / transplantation*
Nephrectomy
Remission Induction
T-Lymphocytes, Regulatory / immunology
T-Lymphocytes, Regulatory / transplantation

Substances

CD8 Antigens
Immunologic Factors
Interferon-alpha
Interleukin-2